IIM
FOLD

INTECH Investment Management’s Amicus Therapeutics FOLD Stock Holding History

INTECH Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Sell
73,758
-29,781
-29% -$427K 0.01% 988
2025
Q4 		$1.47M Hold
103,539
– – 0.01% 905
2025
Q3 		$816K Sell
103,539
-19,476
-16% -$139K 0.01% 1298
2025
Q2 		$705K Sell
123,015
-47,907
-28% -$309K 0.01% 1410
2025
Q1 		$1.39M Buy
170,922
+46,218
+37% +$428K 0.01% 989
2024
Q4 		$1.17M Buy
124,704
+46,633
+60% +$485K 0.01% 1028
2024
Q3 		$834K Buy
+78,071
New +$850K 0.01% 912

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

INTECH Investment Management's FOLD Position: Q1 2026 in Review

INTECH Investment Management reduced its Amicus Therapeutics (FOLD) stake by 29% in Q1 2026, selling an estimated $427K and leaving 73,758 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #988.

INTECH Investment Management first reported a position in FOLD in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.47M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • INTECH Investment Management held 73,758 shares of Amicus Therapeutics worth $1.07M as of Q1 2026.
  • INTECH Investment Management sold 29,781 Amicus Therapeutics shares in Q1 2026, an estimated $427K.
  • Amicus Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #988 holding.
  • INTECH Investment Management first reported a position in Amicus Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Amicus Therapeutics position peaked at $1.47M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.